EUVIMEDEUVIMED entdecken
Crossref

Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism

MEDS Clinical Medicine · 2026 · 7 (1)

DOI: 10.23977/medsc.2026.070109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MEDS Clinical Medicine, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism. MEDS Clinical Medicine, 7(1). https://doi.org/10.23977/medsc.2026.070109

Vancouver

Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism. MEDS Clinical Medicine. 2026;7(1). doi:10.23977/medsc.2026.070109

BibTeX
@article{euvimed2026,
  title = {Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism},
  journal = {MEDS Clinical Medicine},
  year = {2026},
  volume = {7},
  number = {1},
  doi = {10.23977/medsc.2026.070109}
}
Kostenlos starten →